Del 202 - Handbook of Experimental Pharmacology

Urinary Tract

Häftad, Engelska, 2013

Av Karl-Erik Andersson, Martin C. Michel

4 319 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

The basic anatomy and physiology of the urinary tract, the validity of animal models and other methodological considerations as well as a range of potential therapeutic targets are comprehensively reviewed by leading international experts, making this a unique reference source for basic scientists and research-minded clinicians alike

Produktinformation

Utgivningsdatum2013-04-21
Mått155 x 235 x 36 mm
Vikt942 g
FormatHäftad
SpråkEngelska
SerieHandbook of Experimental Pharmacology
Antal sidor580
Upplaga2011
FörlagSpringer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN9783642267222

Tillhör följande kategorier

Urologi inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin
Farmakologi inom Medicin
Fysiologi inom Medicin

Preface.- Overview on the lower urinary tract. Animal models in overactive bladder research. Animal models of stress urinary incontinence. Animal models for benign prostatic hyperplasia. Use of functional imaging to monitor central control of voiding in humans. Neuroanatomy of the lower urinary tract. Anatomy and histology of the lower urinary tract. Neurophysiology of the lower urinary tract. Afferent mechanism in the urinary tract. Urothelial signaling. Interstitial cells of Cajal in the urinary tract. Potential Applications of gene therapy/transfer to the treatment of lower urinary tract diseases/disorders. Specific pharmacokinetic aspects of the urinary tract. α1-Adrenoceptors in the urinary tract. β-Adrenergic receptor subtypes in the urinary tract. Muscarinic acetylcholine receptors in the urinary tract. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. Ion channel modulators and urinary tract function. Neuropeptides in lower urinary tract function. Cannabinoid: potential targets for the treatment of bladder dysfunction. Vasopressin receptors in voiding dysfunction. ATP & P2X purinoceptors in urinary tract disorders. Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract. Rho kinase a common final pathway of various contractile bladder and ureter stimuli.